Advertisement

Abstract

Cerebellum is particularly vulnerable to neurotoxic agents and poisoning. All stages of lifespan can be affected by cerebellar damage due to neurotoxicity, from fetus to the elderly. Elderly patients are more vulnerable to insults, as well as patients with silent cerebellar lesions, such as preexisting structural lesions. Purkinje neurons are a main target of cerebellotoxic substances. The main causes of cerebellar ataxias of toxic origin are acute and chronic ethanol ingestion, drugs, and environmental exposure. Cerebellar structures are among the most sensitive targets of the central nervous system (CNS) to ethanol intake. In addition to ethanol, several drugs can cause an irreversible cerebellar syndrome, such as phenytoin, antineoplastics, lithium salts, and heroin. Environmental causes of neurotoxic ataxias include chronic exposure to metals, benzene derivatives, and hyperthermia. Cerebellar syndrome associated with toxic insults should not be underestimated. In particular, since patients may develop a life-threatening edema of the posterior fossa in several circumstances, urgent management may be required. Prevention measures should be considered.

Keywords

Purkinje Cell Cerebellar Ataxia Neuroleptic Malignant Syndrome Fetal Alcohol Spectrum Disorder Purkinje Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Adamolekun B (2010) Etiology of Konzo, epidemic spastic paraparesis associated with cyanogenic glycosides in cassava: role of thiamine deficiency? J Neurol Sci 296(1–2):30–33PubMedCrossRefGoogle Scholar
  2. Adamolekun B, McCandless DW, Butterworth RF (1997) Epidemic of seasonal ataxia in Nigeria following ingestion of the African silkworm Anaphe venata: role of thiamine deficiency? Metab Brain Dis 12(4):251–258PubMedGoogle Scholar
  3. Aggarwal S, Byrne BD (1991) Massive ischemic cerebellar infarction due to cocaine use. Neuroradiology 33:449–450PubMedCrossRefGoogle Scholar
  4. Ahmed A, Loes DJ, Bressler EL (1995) Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology 45:588–589PubMedCrossRefGoogle Scholar
  5. Al-Rejaie S, Dar MS (2006) Behavioral interaction between nicotine and ethanol: possible modulation by mouse cerebellar glutamate. Alcohol Clin Exp Res 30(7):1223–1233PubMedCrossRefGoogle Scholar
  6. Anand M, Agrawal AK, Rehmani BN, Gupta GS, Rana MD, Seth PK (1998) Role of GABA receptor complex in low dose lindane (HCH) induced neurotoxicity: neurobehavioural, neurochemical and electrophysiological studies. Drug Chem Toxicol 21:35–46PubMedCrossRefGoogle Scholar
  7. Anderson CM, Rabi K, Lukas SE, Teicher MH (2010) Cerebellar lingula size and experiential risk factors associated with high levels of alcohol and drug use in young adults. Cerebellum 9(2):198–209PubMedCrossRefGoogle Scholar
  8. Anselmo M, Campos Rainho A, do Carmo Vale M, Estrada J, Valente R, Correia M, Vieira JP, Barata D (2006) Methadone intoxication in a child: toxic encephalopathy? J Child Neurol 21:618–620PubMedCrossRefGoogle Scholar
  9. Arnaud A, Neau JP, Rivasseau-Jonveaux T, Marechaud R, Gil R (1992) Neurological toxicity of amiodarone. 5 case reports. Rev Med Interne 13:419–422PubMedCrossRefGoogle Scholar
  10. Asaka T, Nitta E, Makifuchi T et al (1995) Germanium intoxication with sensory ataxia. J Neurol Sci 130:220–223PubMedCrossRefGoogle Scholar
  11. Barber DS, Hancock SK, McNally AM, Hinckley J, Binder E, Zimmerman K, Ehrich MF (2007) Jortner BS Neurological effects of acute uranium exposure with and without stress. Neurotoxicology 28(6):1110–1119PubMedCrossRefGoogle Scholar
  12. Barbosa F Jr, Tanus-Santos JE, Gerlach RF, Parsons PJ (2005) A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 113:1669–1674PubMedCrossRefGoogle Scholar
  13. Barona J, Otero R, Núñez V (2004) Toxicological and immunological aspects of scorpion venom (Tytius pachyurus): neutralizing capacity of antivenoms produced in Latin America. Biomedica 24(1):42–49PubMedGoogle Scholar
  14. Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF (1997) Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 21:872–880PubMedCrossRefGoogle Scholar
  15. Baulac M, Cavalcanti D, Semah F, Arzimanoglou A, Portal JJ (1998) Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Seizure 7:55–62PubMedCrossRefGoogle Scholar
  16. Bazille C, Megarbane B, Bensimhon D, Lavergne-Slove A, Baglin AC, Loirat P, Woimant F, Mikol J, Gray F (2005) Brain damage after heat stroke. J Neuropathol Exp Neurol 64:970–975PubMedCrossRefGoogle Scholar
  17. Beasley DM, Glass WI (1998) Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med 48:427–431CrossRefGoogle Scholar
  18. Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13:313–326PubMedCrossRefGoogle Scholar
  19. Beer TM, Higano CS, Saleh M et al (2007) Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel. Invest New Drugs 25(6):565–570PubMedCrossRefGoogle Scholar
  20. Bek K, Koçak S, Ozkaya O, Yilmaz Y, Aydin OF, Taşdöven CS (2007) Carbamazepine poisoning managed with haemodialysis and haemoperfusion in three adolescents. Nephrology 12(1):33–35PubMedCrossRefGoogle Scholar
  21. Belli LS, De Carlis L, Romani F et al (1993) Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant patient. Transpl Int 6:176–178PubMedCrossRefGoogle Scholar
  22. Benagiano V, Lorusso L, Coluccia A, Tarullo A, Flace P, Girolamo F, Bosco L, Cagiano R, Ambrosi G (2005) Glutamic acid decarboxylase and GABA immunoreactivities in the cerebellar cortex of adult rat after prenatal exposure to a low concentration of carbon monoxide. Neuroscience 135:897–905PubMedCrossRefGoogle Scholar
  23. Bhave SV, Ghoda L, Hoffman PL (1999) Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and sites of ethanol action. J Neurosci 19:3277–3286PubMedGoogle Scholar
  24. Boor JW, Hurtig HI (1977) Persistent cerebellar ataxia after exposure to toluene. Ann Neurol 2:440–442PubMedCrossRefGoogle Scholar
  25. Bridge TA, Norton RL, Robertson WO (1994) Pediatric carbamazepine overdoses. Pediatr Emerg Care 10:260–263PubMedCrossRefGoogle Scholar
  26. Camp MC, Feyder M, Ihne J, Palachick B, Hurd B, Karlsson RM, Noronha B, Chen YC, Coba MP, Grant SG, Holmes A (2011) A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference. Addict Biol. doi:10.1111/j.1369-1600.2010.00282.xGoogle Scholar
  27. Carella F, Grassi MP, Savoiardo M, Contri P, Rapuzzi B, Mangoni A (1988) Dystonic-parkinsonian syndrome after cyanide poisoning: clinical and MRI findings. J Neurol Neurosurg Psychiatry 51:1345–1348PubMedCrossRefGoogle Scholar
  28. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21(7):1199–1206PubMedGoogle Scholar
  29. Cecchini AL, Vasconcelos F, Amara SG, Giglio JR, Arantes EC (2006) Effects of Tityus serrulatus scorpion venom and its toxin TsTX-V on neurotransmitter uptake in vitro. Toxicol Appl Pharmacol 217(2):196–203PubMedCrossRefGoogle Scholar
  30. Chan MH, Tang YC, Chien TH, Chen HH (2008) Toluene exposure during the brain growth spurt reduced behavioural responses to nicotine in young adult rats: a potential role for nicotinic acetylcholine receptors in fetal solvent syndrome. Toxicol Sci 101:286–293PubMedCrossRefGoogle Scholar
  31. Chatak NR, Santoso RA, McKinney WN (1976) Cerebellar degeneration following long-term phenytoin therapy. Neurology 26:818–820CrossRefGoogle Scholar
  32. Chatzkel JA, Vossough A (2010) Metronidazole-induced cerebellar toxicity. Pediatr Radiol 40(8):1453PubMedCrossRefGoogle Scholar
  33. Chen WJ, Parnell SE, West JR (1998) Neonatal alcohol and nicotine exposure limits brain growth and depletes cerebellar Purkinje cells. Alcohol 15:33–41PubMedCrossRefGoogle Scholar
  34. Cheong R, Wilson RK, Cortese IC, Newman-Toker DE (2006) Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity. Subst Abus 27:63–67PubMedCrossRefGoogle Scholar
  35. Clarkson TW (1997) The toxicology of mercury. Crit Rev Clin Lab Sci 34:369–403PubMedCrossRefGoogle Scholar
  36. Coentrão L, Moura D (2011) Acute cyanide poisoning among jewelry and textile industry workers. Am J Emerg Med 29(1):78–81PubMedCrossRefGoogle Scholar
  37. Damasceno BP, de Capitani EM (1994) Cerebellar atrophy related to chronic exposure to toluene. Case report. Arq Neuropsiquiatr 52:90–92PubMedCrossRefGoogle Scholar
  38. Daras M, Kakkouras L, Tuchman AJ, Koppel BS (1995) Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? Acta Neurol Scand 92:161–165PubMedCrossRefGoogle Scholar
  39. Darben T, Cominos B, Lee CT (1998) Topical eucalyptus oil poisoning. Australas J Dermatol 39:265–267PubMedCrossRefGoogle Scholar
  40. De Silva PE (1981) Determination of lead in plasma and studies of its relationship to lead in erythrocytes. Br J Ind Med 38:209–217Google Scholar
  41. Deutsch SI, Mastropaolo J, Rosse RB (1998) Neurodevelopmental consequences of early exposure to phencyclidine and related drugs. Clin Neuropharmacol 21:320–332PubMedGoogle Scholar
  42. Diener HC, Dichgans J, Bacher M, Guschlbauer B (1984) Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence. J Neurol 231:258–262PubMedCrossRefGoogle Scholar
  43. Donaldson J (1987) The pathophysiologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8:451–462PubMedGoogle Scholar
  44. Duzova A, Baskin E, Usta Y, Ozen S (2001) Carbamazepine poisoning: treatment with plasma exchange. Hum Exp Toxicol 20(4):175–177PubMedCrossRefGoogle Scholar
  45. Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ (1983) “Baltic” myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet ii:838–842CrossRefGoogle Scholar
  46. Elizur A, Yeret A, Segal Z, Graff E (1982) Lithium and electrolytes plasma/RBC ratio and paradoxical lithium neurotoxicity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:235–241CrossRefGoogle Scholar
  47. Ellenhorn MJ (1997) Anticonvulsants. Ellenhorn’s medical toxicology, 2nd edn. Williams and Wilkins, Pennsylvania, pp 593–614Google Scholar
  48. Epstein-Barash H, Shichor I, Kwon AH, Hall S, Lawlor MW, Langer R, Kohane DS (2009) Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci USA 106:7125–7130PubMedCrossRefGoogle Scholar
  49. Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 56:385–431PubMedCrossRefGoogle Scholar
  50. Fernandes VM, Massensini AR, Prado MA, Silva MA, Moraes-Santos T, Gomez MV (2004) Effects of alpha-scorpion toxin, tityustoxin on the release of [3H] dopamine of rat brain prefrontal cortical slices. Neurochem Int 44(2):91–97PubMedCrossRefGoogle Scholar
  51. Finkelstein Y, Markowitz ME, Rosen JF (1998) Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Brain Res Rev 27:168–176PubMedCrossRefGoogle Scholar
  52. Flora SJ, Pachauri V (2010) Chelation in metal intoxication. Int J Environ Res Public Health 7(7):2745–2788PubMedCrossRefGoogle Scholar
  53. Fonseka MM, Medagoda K, Tillakaratna Y, Gunatilake SB, de Silva HJ (2003) Self-limiting cerebellar ataxia following organophosphate poisoning. Hum Exp Toxicol 22:107–109PubMedCrossRefGoogle Scholar
  54. Frison G, Favretto D, Zancanaro F, Fazzin G, Ferrara SD (2008) A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int 179(2–3):e37–e43PubMedCrossRefGoogle Scholar
  55. Fujimoto M, Ishibashi H, Shimamura R et al (1992) A patient with liver cirrhosis manifesting various symptoms including cerebellar ataxia due to germanium intoxication. Fukuoka Igaku Zasshi 83:139–143PubMedGoogle Scholar
  56. Fukui Y, Miki M, Ukai H, Okamoto S et al (1999) Urinary lead as a possible surrogate of blood lead among workers occupationally exposed to lead. Int Arch Occup Environ Health 72:516–520PubMedCrossRefGoogle Scholar
  57. Gadwalkar SR, Bushan S, Pramod K, Gouda C, Kumar PM (2006) Bilateral cerebellar infarction: a rare complication of scorpion sting. J Assoc Physicians India 54:581–583PubMedGoogle Scholar
  58. Gaggelli E, Kozlowski H, Valensin D et al (2006) Copper homeostasis and neurodegenerative disorders (Alzheimer’s disease, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis). Chem Rev 106:1995–2044PubMedCrossRefGoogle Scholar
  59. Gallucci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R (1990) Wernicke encephalopathy: MR findings in 5 patients. AJNR Am J Neuroradiol 11:887–892PubMedGoogle Scholar
  60. Gamelin E, Gamelin L, Bossi L, Quasthoff S (2002) Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 29:21–33PubMedCrossRefGoogle Scholar
  61. Garcia GB, Biancardi ME, Quiroga AD (2005) Vanadium-induced neurotoxicity in the rat central nervous system: a histo-immunohistochemical study. Drug Chem Toxicol 28:329–344PubMedCrossRefGoogle Scholar
  62. Garretto NS, Rey RD, Kohler G et al (1994) Cerebellar syndrome caused by amiodarone. Arq Neuropsiquiatr 52:575–577PubMedCrossRefGoogle Scholar
  63. Garzon T, Mellibovsky L, Roquer J, Perich X, Diez-Perez A (2002) Ataxic form of central pontine myelinolysis. Lancet Neurol 1(8):517–518PubMedCrossRefGoogle Scholar
  64. Gilman S, Bloedel JR, Lechtenberg R (1981) Disorders of the cerebellum contemporary neurology series. FA. Davis, PhiladelphiaGoogle Scholar
  65. Gilman S, Adams K, Koeppe RA et al (1990) Cerebellar and frontal hypometabolism in alcoholic alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol 28:775–785PubMedCrossRefGoogle Scholar
  66. Gilman S, Koeppe RA, Adams K et al (1996) Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 40:163–171PubMedCrossRefGoogle Scholar
  67. Goasguen J, Lapresle J, Ribot C, Rocquet G (1982) Chronic neurological syndrome resulting from intoxication with metallic uranium. Nouv Presse Med 11:119–121PubMedGoogle Scholar
  68. Gocht A, Colmant HJ (1987) Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 6(6):262–270PubMedGoogle Scholar
  69. Goktas U, Kati I, Yuce HH (2010) Management of a severe carbamazepine overdose with continuous venovenous hemodiafiltration. Am J Emerg Med 28(2):260.e1–260.e2CrossRefGoogle Scholar
  70. Gonzalez-Polo RA, Rodriguez-Martin A, Moran JM, Niso M, Soler G, Fuentes JM (2004) Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res 1011:170–176PubMedCrossRefGoogle Scholar
  71. Gordon MF, Abrams RI, Rubin DB, Barr WB, Correa DD (1995) Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord 10:220–222PubMedCrossRefGoogle Scholar
  72. Graves TD, Condon M, Loucaidou M, Perry RJ (2009) Reversible metronidazole-induced cerebellar toxicity in a multiple transplant patient. J Neurol Sci 285:238–240PubMedCrossRefGoogle Scholar
  73. Greenwood J, Jeyasingham M, Pratt OE et al (1984) Heterogeneity of human erythrocyte transketolase: a preliminary report. Alcohol Alcohol 19:123–129PubMedGoogle Scholar
  74. Grignon S, Bruguerolle B (1996) Cerebellar lithium toxicity: a review of recent literature and tentative pathophysiology. Therapie 51:101–106PubMedGoogle Scholar
  75. Guilarte TR, Chen MK (2007) Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects. Neurotoxicology 28:1147–1152PubMedCrossRefGoogle Scholar
  76. Harper CG (1983) The incidence of Wernicke’s encephalopathy in Australia – a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 46:593–598PubMedCrossRefGoogle Scholar
  77. Hasan M, Ashraf I, Bajpai VK (1978) Electron microscopic study of the effects of thallium poisoning on the rat cerebellum. Forensic Sci 11:139–146PubMedGoogle Scholar
  78. Haubek A, Lee K (1979) Computed tomography in alcoholic cerebellar atrophy. Neuroradiology 18:77–79PubMedCrossRefGoogle Scholar
  79. Heaney CJ, Campeau NG, Lindell EP (2003) MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. AJNR Am J Neuroradiol 24:1615–1617PubMedGoogle Scholar
  80. Helldén A, Bergman U, Engström Hellgren K, Masquelier M, Nilsson Remahl I, Odar-Cederlöf I, Ramsjö M, Bertilsson L (2010) Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9. Eur J Clin Pharmacol 66(8):791–795PubMedCrossRefGoogle Scholar
  81. Herculano AM, Crespo-Lopez ME, Lima SM, Picanco-Diniz DL, Nascimento DL (2006) Methymercury intoxication activates nitric oxide synthase in chick retinal cell culture. Braz J Med Biol Res 39:415–418PubMedCrossRefGoogle Scholar
  82. Hernández-Viadel M, Castoldi AF, Coccini T, Manzo L, Erceg S, Felipo V (2004) In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum. J Neurochem 89:1157–1165PubMedCrossRefGoogle Scholar
  83. Herzig RH, Hines JD, Herzig GP et al (1987) Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol 5:927–932PubMedGoogle Scholar
  84. Hester R, Garavan H (2004) Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24(49):11017–11022PubMedCrossRefGoogle Scholar
  85. Hill SY, Muddasani S, Prasad K, Nutche J, Steinhauer SR, Scanlon J, McDermott M, Keshavan M (2007) Cerebellar volume in offspring from multiplex alcohol dependence families. Biol Psychiatry 61(1):41–47PubMedCrossRefGoogle Scholar
  86. Himi T, Ikeda M, Sato I, Yuasa T, Murata S (1996) Purkinje cells express neuronal nitric oxide synthase after methylmercury administration. Brain Res 718:189–192PubMedCrossRefGoogle Scholar
  87. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500PubMedCrossRefGoogle Scholar
  88. Ho G, Keutgens A, Schoofs R, Kotolenko S, Denooz R, Charlier C (2011) Blood, urine, and hair kinetic analysis following an acute lead intoxication. J Anal Toxicol 35(1):60–64PubMedCrossRefGoogle Scholar
  89. Hori A, Kazakuwa S, Fujii T, Kurachi M (1987) Lennox-Gastaut syndrome with and without Dandy-Walker malformation. Epilepsy Res 1:258–261PubMedCrossRefGoogle Scholar
  90. Houi K, Oka H, Mochio S (1993) The effects of nicotine on a patient with spinocerebellar degeneration whose symptoms were temporarily exacerbated by cigarette smoking. Rinsho Shinkeigaku 33:774–776PubMedGoogle Scholar
  91. Ikeda M, Tsukagoshi H (1990) Encephalopathy due to toluene sniffing. Report of a case with magnetic resonance imaging. Eur Neurol 30:347–349PubMedCrossRefGoogle Scholar
  92. Ishii K, Tamaoka A, Otsuka F et al (2004) Diphenylarsinic acid poisoning from chemical weapons in Kamisu, Japan. Ann Neurol 56:741–745PubMedCrossRefGoogle Scholar
  93. Ishizaki M, Yanaoka T, Nakamura M, Hakuta T, Ueno S, Komuro M, Shibata M, Kitamura T, Susuki Y, Sakamoto A, Honda A, Hanaoka S, Ogata T, Doi M (2003) Detection of phenylated arsenic compounds from the well water. In: Proceedings of the 11th annual meeting of arsenic research in Japan. Japanese Arsenic Scientist’s Society, Sapporo, pp 43–44Google Scholar
  94. Iurlo M, Leone G, Schilström B, Linnér L, Nomikos G, Hertel P, Silvestrini B, Svensson H (2001) Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition. Psychopharmacology (Berl) 159(1):98–104CrossRefGoogle Scholar
  95. Jaatinen P, Rintala J (2008) Mechanisms of ethanol-induced degeneration in the developing, mature, and aging cerebellum. Cerebellum 7(3):332–347PubMedCrossRefGoogle Scholar
  96. Jefferson JW (2002) Rediscovering the art of lithium therapy. Curr Psychiatry 1:12Google Scholar
  97. Johnsen JA, Miller VT (1986) Tobacco intolerance in multiple system atrophy. Neurology 36:986–988PubMedCrossRefGoogle Scholar
  98. Johnson LM, Hubble JP, Koller WC (1993) Effect of medications and toxins on cerebellar function. In: Lechtenberg R (ed) Handbook of cerebellar diseases. Marcel Dekker, New YorkGoogle Scholar
  99. Kaleyias J, Faerber E, Kothare SV (2006) Tacrolimus induced subacute cerebellar ataxia. Eur J Paediatr Neurol 10:86–89PubMedCrossRefGoogle Scholar
  100. Kaprio J, Koskenvuo M, Langinvainio H, Romanov K, Sarna S, Rose RJ (1987) Genetic influences on use and abuse of alcohol: a study of 5638 adult Finnish twin brothers. Alcohol Clin Exp Res 11(4):349–356PubMedCrossRefGoogle Scholar
  101. Kato K, Mizoi M, An Y, Nakano M, Wanibuchi H, Endo G, Endo Y, Hoshino M, Okada S, Yamanaka K (2007) Oral administration of diphenylarsinic acid, a degradation product of chemical warfare agents, induces oxidative and nitrosative stress in cerebellar Purkinje cells. Life Sci 81:1518–1525PubMedCrossRefGoogle Scholar
  102. Katz AA, Hoffman RS, Silverman RA (1993) Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann Emerg Med 22:1485–1487PubMedCrossRefGoogle Scholar
  103. Kim JM, Jeon BS (2009) Survivors from beta-fluoroethyl acetate poisoning show a selective cerebellar syndrome. J Neurol Neurosurg Psychiatry 80:528–532PubMedCrossRefGoogle Scholar
  104. Kim H, Sablin SO, Ramsay RR (1997) Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys 337(1):137–142PubMedCrossRefGoogle Scholar
  105. Kim J, Song T, Park S, Choi IS (2007) Cerebellar peduncular myelinolysis in a patient receiving hemodialysis. J Neurol Sci 253(1–2):66–68PubMedCrossRefGoogle Scholar
  106. King MD (1982) Neurological sequelae of toluene abuse. Hum Toxicol 1:281–287PubMedCrossRefGoogle Scholar
  107. Klaassen CD (2006) Heavy metals and heavy metal antagonists. In: Goodman L, Gilman A (eds) The pharmacological basis of therapeutics. McGraw Hill/Medical Publishing Division, New York, pp 1825–1872Google Scholar
  108. Klos KJ, Chandler M, Kumar N, Ahiskog JE, Josephs KA (2006) Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol 13:1139–1141PubMedCrossRefGoogle Scholar
  109. Köppel C (1993) Clinical symptomatology and management of mushroom poisoning. Toxicon 31(12):1513–1540PubMedCrossRefGoogle Scholar
  110. Korogi Y, Takahashi M, Sumi M et al (1994) MR imaging of Minamata disease: qualitative and quantitative analysis. Radiat Med 12:249–253PubMedGoogle Scholar
  111. Korogi Y, Takahashi M, Okajima T, Eto K (1998) MR findings in Minamata disease. J Magn Reson Imaging 8:308–316PubMedCrossRefGoogle Scholar
  112. Kosel M, Noss RS, Hämmig R, Wielepp P, Bundeli P, Heidbreder R, Kinser JA, Brenneisen R, Fisch HU, Kayser S, Schlaepfer TE (2008) Cerebral blood flow effects of acute intravenous heroin administration. Eur Neuropsychopharmacol 18(4):278–285PubMedCrossRefGoogle Scholar
  113. Kulakowska A, Drozdowski W, Halicka D, Kochanowicz J (2000) Neurologic and psychiatric sequelae of carbon monoxide poisoning. Neurol Neurochir Pol 34:587–595PubMedGoogle Scholar
  114. Kumada T, Komuro Y, Li Y, Hu T, Wang Z, Littner Y, Komuro H (2010) Inhibition of cerebellar granule cell turning by alcohol. Neuroscience 170(4):1328–1344PubMedCrossRefGoogle Scholar
  115. Kumar A (2002) Movement disorders in the tropics. Parkinsonism Relat Disord 9(2):69–75PubMedCrossRefGoogle Scholar
  116. Kuruvilla T, Bharucha NE (1997) Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 38:500–502PubMedCrossRefGoogle Scholar
  117. Laforenza U, Patrini C, Gastaldi G, Rindi G (1990) Effects of acute and chronic ethanol administration on thiamine metabolizing enzymes in some brain areas and in other organs of the rat. Alcohol Alcohol 25(6):591–603PubMedGoogle Scholar
  118. Larsen A, Stoltenberg M, West MJ, Danscher G (2005) Influence of bismuth on the number of neurons in cerebellum and hippocampus of normal and hypoxia-exposed mouse brain: a stereological study. J Appl Toxicol 25:383–392PubMedCrossRefGoogle Scholar
  119. Lawden MC, Blunt S, Matthews T, Peatfield R, Kennard C (1994) Recurrent confusion and ataxia triggered by pyrexia in a case of occult multiple sclerosis. J Neurol Neurosurg Psychiatry 57:1436PubMedCrossRefGoogle Scholar
  120. Lesnik PG, Ciesielski KT, Hart BL et al (1998) Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy foe leukemia: enhanced data analysis using an effect size model. Arch Neurol 55:1561–1568PubMedCrossRefGoogle Scholar
  121. Li X, Yin J, Cheng CM, Sun JL, Wu YL (2005) Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Chin Med J 118:1357–1361PubMedGoogle Scholar
  122. Linares V, Sánchez DJ, Bellés M, Albina L, Gómez M, Domingo JL (2007) Pro-oxidant effects in the brain of rats concurrently exposed to uranium and stress. Toxicology 236(1–2):82–91PubMedCrossRefGoogle Scholar
  123. Llansola M, Montoliu C, Boix J, Felipo V (2010) Polychlorinated biphenyls PCB 52, PCB 180, and PCB 138 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms. Chem Res Toxicol 23(4):813–820PubMedCrossRefGoogle Scholar
  124. Lodenius M, Malm O (1998) Mercury in the Amazon. Rev Environ Contam Toxicol 157:25–52PubMedCrossRefGoogle Scholar
  125. Malbrain ML, Lambrecht GL, Zandijk E et al (1997) Treatment of severe thallium intoxication. J Toxicol Clin Toxicol 35:97–100PubMedCrossRefGoogle Scholar
  126. Mani J, Chaudhary N, Kanjalkar M, Shah PU (1998) Cerebellar ataxia due to lead encephalopathy in an adult. J Neurol Neurosurg Psychiatry 65:797PubMedCrossRefGoogle Scholar
  127. Manto M (2010a) Cerebellar disorders. A practical approach to diagnosis and management. Cambridge University Press, Cambridge, UKCrossRefGoogle Scholar
  128. Manto M (2010b) Cerebellar lingula thickness as a novel risk factor for alcohol and drug abuse. Cerebellum 9(2):145–147PubMedCrossRefGoogle Scholar
  129. Manto M (2011) Toxic agents causing cerebellar ataxias. Handb Clin Neurol 103:201–213CrossRefGoogle Scholar
  130. Manto MU, Jacquy J (2002) Other cerebellotoxic agents. In: Manto MU, Pandolfo M (eds) The cerebellum and its disorders. Cambridge University Press, Cambridge, pp 342–366Google Scholar
  131. Manto MU, Topka H (1996) Reversible cerebellar gait ataxia with postural tremor during episodes of high pyrexia. Clin Neurol Neurosurg 98:227–230PubMedCrossRefGoogle Scholar
  132. Manto M, Godaux E, Jacquy J, Hildebrand J (1996) Analysis of cerebellar dysmetria associated with lithium intoxication. Neurol Res 18:416–424PubMedGoogle Scholar
  133. Manto M, Laute MA, Pandolfo M (2005) Depression of extra-cellular GABA and increase of NMDA-induced nitric oxide following acute intra-nuclear administration of alcohol in the cerebellar nuclei of the rat. Cerebellum 4(4):230–238PubMedCrossRefGoogle Scholar
  134. Manzano H, de Sousa AB, Soto-Blanco B, Guerra JL, Maiorka PC, Górniak SL (2007) Effects of long-term cyanide ingestion by pigs. Vet Res Commun 31(1):93–104PubMedCrossRefGoogle Scholar
  135. Marmolino D, Manto M (2010) Pregabalin antagonizes copper-induced toxicity in the brain: in vitro and in vivo studies. Neurosignals 18(4):210–22PubMedCrossRefGoogle Scholar
  136. Mascalchi M, Petruzzi P, Zampa V (1996) MRI of cerebellar white matter damage due to carbon monoxide poisoning: case report. Neuroradiology 38:73–74CrossRefGoogle Scholar
  137. Masland RL (1982) Carbamazepine neurotoxicity. In: Woodbury DM, Penry JK, Pippenger CE (eds) Antiepileptic drugs, 2nd edn. Raven, New York, pp 521–531Google Scholar
  138. Masur H, Elger CE, Ludolph AC, Galanski M (1989) Cerebellar atrophy following acute intoxication with phenytoin. Neurology 39:432–433PubMedCrossRefGoogle Scholar
  139. Meggs WJ, Cahill-Morasco R, Shih RD, Goldfrank LR, Hoffman RS (1997) Effects of Prussian blue and N-acetylcysteine on thallium toxicity in mice. J Toxicol Clin Toxicol 35:163–166PubMedCrossRefGoogle Scholar
  140. Miller VM, Kahnke T, Neu N, Sanchez-Morrissey SR, Brosch K, Kelsey K, Seegal RF (2010) Developmental PCB exposure induces hypothyroxinemia and sex-specific effects on cerebellum glial protein levels in rats. Int J Dev Neurosci 28(7):553–560PubMedCrossRefGoogle Scholar
  141. Mills F, MacLennan SC, Devile CJ, Saunders DE (2008) Severe cerebellitis following methadone poisoning. Pediatr Radiol 38:227–229PubMedCrossRefGoogle Scholar
  142. Moertel CG, Reitemeier RJ, Bolton CE, Shorter RG (1964) Cerebellar ataxia associated with fluorinated pyrimidine therapy. Cancer Chemother Rep 41:15–18PubMedGoogle Scholar
  143. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529–540PubMedCrossRefGoogle Scholar
  144. Morales Odia Y, Jinka M, Ziai WC (2010) Severe leukoencephalopathy following acute oxycodone intoxication. Neurocrit Care 13:93–97PubMedCrossRefGoogle Scholar
  145. Mourre C, Widmann C, Lazdunski M (1990) Saxitoxin-sensitive Na+ channels: presynaptic localization in cerebellum and hippocampus of neurological mutant mice. Brain Res 533:196–202PubMedCrossRefGoogle Scholar
  146. Murata K, Iwata T, Dakeishi M, Karita K (2009) Lead toxicity: does the critical level of lead resulting adverse effects differ between adults and children ? J Occup Health 51(1):1–12PubMedCrossRefGoogle Scholar
  147. Nakamura M, Yasutake A, Fujimura M, Hachiya N, Marumoto M (2010) Effect of methylmercury administration on choroid plexus function in rats. Arch ToxicolGoogle Scholar
  148. Nencioni AL, Lebrun I, Dorce VA (2003) A microdialysis study of glutamate concentration in the hippocampus of rats after TsTX toxin injection and blockade of toxin effects by glutamate receptor antagonists. Pharmacol Biochem Behav 74(2):455–463PubMedCrossRefGoogle Scholar
  149. Niemann B, Rochlitz C, Herrmann R, Pless M (2004) Toxic encephalopathy induced by capecitabine. Oncology 66:331–335PubMedCrossRefGoogle Scholar
  150. Nussbaum ES, Maxwell RE, Bitterman PB, Hertz MI, Bula W, Latchaw RE (1995) Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report. J Neurosurg 82:1068–1070PubMedCrossRefGoogle Scholar
  151. O’Donnell P, Buxton PJ, Pitkin A, Jarvis LJ (2000) The magnetic resonance imaging appearances of the brain in acute carbon monoxide poisoning. Clin Radiol 55:273–280PubMedCrossRefGoogle Scholar
  152. Oehmichen M, Meissner C, Reiter A, Birkholz M (1996) Neuropathology in non-human immunodeficiency virus-infected drug-addicts: hypoxic brain damage after chronic intravenous drug abuse. Acta Neuropathol 91:642–646PubMedCrossRefGoogle Scholar
  153. Orr CF, Ahlskog JE (2009) Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol 66:865–869PubMedCrossRefGoogle Scholar
  154. Ozsoy S, Basturk M, Esel E (2006) Cerebellar syndrome in a patient with pneumonia under lithium treatment: a case report. Prog Neuro-Psychopharmacol Biol Psychiatry 30:1532–1534CrossRefGoogle Scholar
  155. Pahwa R (1997) Toxin-induced parkinsonian syndromes. In: Watts RL, Koller WC (eds) Movement disorders. McGraw Hill, New York, pp 315–323Google Scholar
  156. Palmer BF, Toto RD (1991) Severe neurologic toxicity induced by cyclosporine. A in three renal transplant patients. Am J Kidney Dis 1:116–121Google Scholar
  157. Pappas CL, Quisling RG, Ballinger WE, Love LC (1986) Lead encephalopathy: symptoms of a cerebellar mass lesion and obstructive hydrocephalus. Surg Neurol 26:391–394PubMedCrossRefGoogle Scholar
  158. Pardal PP, Castro LC, Jennings E, Pardal JS, Monteiro MR (2003) Epidemiological and clinical aspects of scorpion envenomation in the region of Santarem, Para, Brazil. Rev Soc Bras Med Trop 36:349–353PubMedCrossRefGoogle Scholar
  159. Pearson GS, Magee RS (2002) Critical evaluation of proven chemical weapon destruction technologies. Pure Appl Chem 74:187–316CrossRefGoogle Scholar
  160. Peddy SB, Rigby MR, Shaffner DH (2006) Acute cyanide poisoning. Pediatr Crit Care Med 7(1):79–82PubMedCrossRefGoogle Scholar
  161. Pentney R (2002) Alcohol toxicity in the cerebellum: fundamental aspects. In: Manto M, Pandolfo M (eds) The cerebellum and its disorders. Cambridge University Press, Cambridge, pp 327–335Google Scholar
  162. Pfab R, Haberl B, Kleber J, Zilker T (2008) Cerebellar effects after consumption of edible morels (Morchella conica, Morchella esculenta). Clin Toxicol (Phila) 46(3):259–260CrossRefGoogle Scholar
  163. Pierce DR, Kane CJ, Serbus DC, Light KE (1997) Microencephaly and selective decreases in cerebellar Purkinje cell numbers following combined exposure to ethanol and methadone during rat brain development. Dev Neurosci 19(5):438–445PubMedCrossRefGoogle Scholar
  164. Playford RJ, Matthews CH, Campbell MJ et al (1990) Bismuth induced encephalopathy caused by tri-potassium dicitrato bismuthate in a patient with chronic renal failure. Gut 31:359–360PubMedCrossRefGoogle Scholar
  165. Popescu BF, Robinson CA, Rajput A et al (2009a) Iron, copper, and zinc distribution of the cerebellum. Cerebellum 8:74–79PubMedCrossRefGoogle Scholar
  166. Popescu BF, Robinson CA, Chapman LD, Nichol H (2009b) Synchrotron X-ray fluorescence reveals abnormal metal distributions in brain and spinal cord in spinocerebellar ataxia: a case report. Cerebellum 8:340–351PubMedCrossRefGoogle Scholar
  167. Rachinger J, Fellner FA, Stieglbauer K, Trenkler J (2002) MR changes after acute cyanide intoxication. AJNR Am J Neuroradiol 23(8):1398–1401PubMedGoogle Scholar
  168. Rai A, Maurya SK, Khare P, Srivastava A, Bandyopadhyay S (2010) Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol Sci 118(2):586–601PubMedCrossRefGoogle Scholar
  169. Rangi PS, Partridge WJ, Newlands ES, Waldman AD (2005) Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Neuroradiology 47:586–590PubMedCrossRefGoogle Scholar
  170. Rhodes FA, Mills CG, Popei K (1975) Paralytic shellfish poisoning in Papua New Guinea. P N G Med J 18:197–202PubMedGoogle Scholar
  171. Rittmannsberger H, Lebhuler F (1992) Asterixis induced by carbamazepine. Biol Psychiatry 32:364–368PubMedCrossRefGoogle Scholar
  172. Riudavets MA, Aronica-Pollak P, Troncoso JC (2005) Pseudolaminar necrosis in cyanide intoxication: a neuropathology case report. Am J Forensic Med Pathol 26(2):189–191PubMedGoogle Scholar
  173. Roegge CS, Schantz SL (2006) Motor function following developmental exposure to PCBs and/or MeHg. Neurotoxicol Teratol 28:260–277PubMedCrossRefGoogle Scholar
  174. Rosenow F, Herholz K, Lanfermann H et al (1995) Neurological sequelae of cyanide intoxication – the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings. Ann Neurol 38:825–828PubMedCrossRefGoogle Scholar
  175. Rothner AD, Pippenger C, Cruse RP, Erenberg G, Wyllie E, Zabukovec M (1987) Carbamazepine toxicity with therapeutic total levels and elevated free levels. Ann Neurol 22:413–414Google Scholar
  176. Roy M, Stip E, Black D, Lew V, Langlois R (1998) Cerebellar degeneration following acute lithium intoxication. Rev Neurol 154:546–548PubMedGoogle Scholar
  177. Ryan A, Molloy FM, Farrell MA, Hutchinson M (2005) Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J Neurol Neurosurg Psychiatry 76:1014–1016PubMedCrossRefGoogle Scholar
  178. Sabbioni E, Manzo L (1980) Metabolism and toxicity of thallium. In: Manzo L (ed) Advances in neurotoxicology. Pergamon, Oxford, pp 249–270Google Scholar
  179. Saito K, Wada H (1993) Behavioral approaches to toluene intoxication. Environ Res 62:53–62PubMedCrossRefGoogle Scholar
  180. Sanders T, Liu Y, Buchner V, Tchounwou PB (2009) Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 24:15–45PubMedCrossRefGoogle Scholar
  181. Saviuc P, Harry P, Pulce C, Garnier R, Cochet A (2010) Can morels (Morchella sp.) induce a toxic neurological syndrome? Clin Toxicol (Phila) 48(4):365–372CrossRefGoogle Scholar
  182. Savoldi F, Mazzella GL, Bo P, Massarini M (1973) Cerebellar ataxia due to acute carbon monoxide poisoning. Riv Neurobiol 19:197–206PubMedGoogle Scholar
  183. Schuckit MA (1985) Ethanol-induced changes in body sway in men at high alcoholism risk. Arch Gen Psychiatry 42(4):375–379PubMedCrossRefGoogle Scholar
  184. Schwartz RH, Einhorn A (1986) PCP intoxication in seven young children. Pediatr Emerg Care 2:238–241PubMedCrossRefGoogle Scholar
  185. Schwartz AB, Klausner SC, Yee S, Turchyn M (1984) Cerebellar ataxia due to procainamide toxicity. Arch Intern Med 144:2260–2261PubMedCrossRefGoogle Scholar
  186. Selhorst JB, Kaufman B, Horwitz SJ (1972) Diphenylhydantoin-induced cerebellar degeneration. Arch Neurol 27:452–455CrossRefGoogle Scholar
  187. Senanayake N (1987) Delayed cerebellar ataxia: a new complication of falciparum malaria? Br Med J (Clin Res Ed) 294(6582):1253–1254CrossRefGoogle Scholar
  188. Shibuki K, Kimura S, Wakatsuki H (2001) Suppression of the induction of long-term depression by carbon monoxide in rat cerebellar slices. Eur J Neurosci 13:609–616PubMedCrossRefGoogle Scholar
  189. Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O, Suno M, Ogawa K, Hayase N, Kimura K, Shiono H (2001) Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res 906:135–142PubMedCrossRefGoogle Scholar
  190. Shimuzu K, Matsubara K, Ohtaki K, Fujimaru S, Saito O, Shiono H (2003) Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 976:243–252CrossRefGoogle Scholar
  191. Silbergeld EK (1993) New approaches to monitoring environmental neurotoxins. Ann N Y Acad Sci 694:62–71PubMedCrossRefGoogle Scholar
  192. Simard M, Gumbiner B, Lee A, Lewis H, Norman D (1989) Lithium carbonate intoxication. A case report and review of the literature. Arch Intern Med 149:36–46PubMedCrossRefGoogle Scholar
  193. Singh YN, Singh NN (2002) Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 16:731–743PubMedCrossRefGoogle Scholar
  194. Sowell ER, Jernigan TL, Mattson SN et al (1996) Abnormal development of the cerebellar vermis in children prenatally exposed to alcohol: size reduction in lobules I–V. Alcohol Clin Exp Res 20:31–34PubMedCrossRefGoogle Scholar
  195. Specht U, May TW, Rohde M et al (1997) Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. Arch Neurol 54:427–431PubMedCrossRefGoogle Scholar
  196. Spencer PS, Schaumburg HH (eds) (1980) Experimental and clinical neurotoxicology. Williams and Wilkins, BatimoreGoogle Scholar
  197. Squier W, Hope PL, Lindenbaum RH (1990) Neocerebellar hypoplasia in a neonate following intra-uterine exposure to anti-convulsants. Dev Med Child Neurol 32:737–742PubMedCrossRefGoogle Scholar
  198. Stelmashook EV, Isaev NK, Zorov DB (2007) Paraquat potentiates glutamate toxicity in immature cultures of cerebellar granule neurons. Toxicol Lett 174:82–88PubMedCrossRefGoogle Scholar
  199. Stengard K, Tham R, O’Connor WT, Hoglund G, Ungerstedt U (1993) Acute toluene exposure increases extra-cellular GABA in the cerebellum of rat: a microdialysis study. Pharmacol Toxicol 73:315–318PubMedCrossRefGoogle Scholar
  200. Takahashi M, Aki T, Yasuhara M, Maekawa T, Yoshida K, Uemura K, Harada K, Sadamitsu D, Tsuruta R (2001) Apoptotic and necrotic brain lesions in a fatal case of carbon monoxide poisoning. Forensic Sci Int 116:213–219PubMedCrossRefGoogle Scholar
  201. Taskapilioglu O, Seferoglu M, Kaygili E, Hakyemez B, Zarifoglu M (2010) Reversible cerebellar toxicity during treatment with ornidazole: the first case report. J Neurol Neurosurg Psychiatry 81(3):349–350PubMedCrossRefGoogle Scholar
  202. Thompson CB, June CH, Sullivan KM, Thomas ED (1984) Association between cyclosporin neurotoxicity and hypomagnesemia. Lancet ii:1116–1120CrossRefGoogle Scholar
  203. Tibballs J (1995) Clinical effects and management of eucalyptus oil ingestion in infants and young children. Med J Aust 163:177–180PubMedGoogle Scholar
  204. Tonge JI, Burry AF, Saal JR (1977) Cerebellar calcification: a possible marker of lead poisoning. Pathology 9:289–300PubMedCrossRefGoogle Scholar
  205. Tripathi SK, Pandey SK (2007) The effect of aluminium phosphide on the human brain: a histological study. Med Sci Law 47:141–146PubMedCrossRefGoogle Scholar
  206. Tsan YT, Peng KY, Hung DZ, Hu WH, Yang DY (2005) Case report: the clinical toxicity of dimethylamine borane. Environ Health Perspect 113(12):1784–1786PubMedCrossRefGoogle Scholar
  207. Uchino A, Kato A, Yuzuriha T, Takashima Y, Hiejima S, Murakami M, Endoh K, Yoshikai T, Kudo S (2002) Comparison between patient characteristics and cranial MR findings in chronic thinner intoxication. Eur Radiol 12:1338–1341PubMedCrossRefGoogle Scholar
  208. Vergauwe PL, Knockaert DC, Van Tittelbaum TJ (1990) Near fatal subacute thallium poisoning necessitating prolonged mechanical ventilation. Am J Emerg Med 8:548–550PubMedCrossRefGoogle Scholar
  209. Victor M, Adams RD, Mancall EL (1959) A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1:579–688CrossRefGoogle Scholar
  210. Vogel H, Horoupian DS (1993) Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity. Cancer 71(4):1303–1308PubMedCrossRefGoogle Scholar
  211. Vorperian VR, Havighurst TC, Miller S, January CT (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791–798PubMedCrossRefGoogle Scholar
  212. Wainwright AP, Kox WJ, House IM, Henry JA, Heaton R, Seed WA (1988) Clinical features and therapy of acute thallium poisoning. Q J Med 69:939–944PubMedGoogle Scholar
  213. Wang ZY, Miki T, Lee KY, Yokoyama T, Kusaka T, Sumitani K, Warita K, Matsumoto Y, Yakura T, Hosomi N, Ameno K, Bedi KS, Takeuchi Y (2010) Short-term exposure to ethanol causes a differential response between nerve growth factor and brain-derived neurotrophic factor ligand/receptor systems in the mouse cerebellum. Neuroscience 165(2):485–491PubMedCrossRefGoogle Scholar
  214. Weber W, Henkes H, Möller P, Bade K, Kühne D (1998) Toxic spongiform leucoencephalopathy after inhaling heroin vapour. Eur Radiol 8(5):749–755PubMedCrossRefGoogle Scholar
  215. Welch L, Kirshner H, Heath A, Gilliland R, Broyles S (1991) Chronic neuropsychological and neurological impairment following acute exposure to a solvent mixture of toluene and methyl ethyl ketone (MEK). J Toxicol Clin Toxicol 29(4):435–445PubMedCrossRefGoogle Scholar
  216. Wizniter M, Packer RJ, Rorke LB, Meadows AT (1987) Cerebellar sclerosis in pediatric cancer patients. J Neurooncol 4:353–360PubMedCrossRefGoogle Scholar
  217. Wong R, Beguelin GZ, de Lima M, Giralt SA, Hosing C, Ippoliti C, Forman AD, Kumar AJ, Champlin R, Couriel D (2003) Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 122(1):128–134PubMedCrossRefGoogle Scholar
  218. Worner TM (1993) Effects of alcohol. In: Lechtenberg R (ed) Handbook of cerebellar diseases. Marcel Dekker, New York, pp 547–566Google Scholar
  219. Xiao L, Lin X, Cao J, Wang X, Wu LE (2010) MRI findings in 6 cases of children by inadvertent ingestion of diphenoxylate-atropine. Eur J RadiolGoogle Scholar
  220. Yamanouchi N, Okada S, Kodama K et al (1995) White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 16:1643–1649PubMedGoogle Scholar
  221. Yamashita T, Ando Y, Sakashita N, Hirayama K, Tanaka Y, Tashima K et al (1997) Role of nitric oxide in the cerebellar degeneration during methymercury intoxication. Biochim Biophys Acta 1334(2–3):303–311CrossRefGoogle Scholar
  222. Yaqhb B, Al Deeb S (1998) Heat strokes: aetiopathogenesis, neurological characteristics, treatment and outcome. J Neurol Sci 156:144–151CrossRefGoogle Scholar
  223. Yokoyama K, Araki S, Murata K et al (1997) Subclinical vestibulo-cerebellar, anterior cerebellar lobe and spinocerebellar effects in lead workers in relation to concurrent and past exposure. Neurotoxicology 18:371–380PubMedGoogle Scholar
  224. Zanin A, Masiero S, Severino MS, Calderone M, Da Dalt L, Laverda AM (2010) A delayed methadone encephalopathy: clinical and neuroradiological findings. J Child Neurol 25(6):748–751PubMedCrossRefGoogle Scholar
  225. Zhang P, Sun M, Qiu R, Tang L, Dou G, Xu B (2011) Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors. Cancer Chemother Pharmacol (Epub ahead of print)Google Scholar
  226. Zimetbaum P (2007) Amiodarone for atrial fibrillation. N Engl J Med 356:935–941PubMedCrossRefGoogle Scholar
  227. Zitelli BJ, Howrie DL, Altman H, Maroon TJ (1987) Erythromycin-induced drug interactions. An illustrative case and review of the literature. Clin Pediatr 26:117–119CrossRefGoogle Scholar
  228. Zubaran C, Fernandes JG, Rodnight R (1997) Wernicke-Korsakoff syndrome. Postgrad Med J 73:27–31PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Unité d’Etude du Mouvement (UEM)FNRS, Neurologie ULB ErasmeBruxellesBelgium

Personalised recommendations